Neurogene Inc. (NGNE)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
18.47
0.58 (3.24%)
At close: Jan 15, 2025, 3:57 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
Revenue | n/a | n/a | n/a | n/a | n/a | 25.00M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 3.26M | 3.20M | 2.28M | 1.82M | 340.00K | n/a | n/a | n/a | n/a | 135.95K | 59.57K | 130.78K | 125.60K |
Gross Profit | -3.26M | -3.20M | -2.28M | -1.82M | -340.00K | 25.00M | n/a | n/a | n/a | -135.95K | -59.57K | -130.78K | -125.60K |
Operating Income | -55.58M | -56.52M | -50.53M | -41.55M | -24.44M | -23.52M | -51.12M | -37.65M | -21.34M | -22.38M | -9.38M | -7.68M | -10.43M |
Interest Income | 2.95M | 1.34M | 17.00K | 490.00K | 1.54M | 1.56M | 998.00K | 619.00K | n/a | n/a | 26.32K | 10.80K | 19.75K |
Pretax Income | -36.32M | -55.19M | -50.52M | -33.28M | -69.44M | -31.59M | -50.18M | -37.00M | -21.86M | -24.03M | -8.73M | -7.67M | -10.66M |
Net Income | -36.32M | -55.19M | -50.52M | -33.28M | -69.44M | -31.59M | -50.18M | -37.00M | -21.86M | -23.82M | -8.73M | -7.71M | -10.51M |
Selling & General & Admin | 11.19M | 9.01M | 8.27M | 15.39M | 17.79M | 15.73M | 14.85M | 9.26M | 5.54M | 4.30M | 1.78M | 1.64M | 1.73M |
Research & Development | 44.39M | 47.51M | 42.26M | 24.34M | 6.32M | 32.79M | 36.27M | 28.38M | 15.80M | 17.94M | 7.54M | 5.91M | 8.58M |
Other Expenses | -28.00K | -7.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 55.58M | 56.52M | 50.53M | 39.73M | 24.10M | 48.52M | 51.12M | 37.65M | 21.34M | 22.24M | 9.32M | 7.55M | 10.30M |
Interest Expense | 12.00K | 2.00K | n/a | n/a | 1K | 4.00K | 4.00K | 1K | 99.00K | 2.25M | 42.92K | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 55.58M | 56.52M | 50.53M | 41.55M | 24.44M | 48.52M | 51.12M | 37.65M | 21.34M | 22.38M | 9.38M | 7.68M | 10.43M |
Income Tax | n/a | -5.00K | 17.00K | -1 | 168.14K | n/a | -1 | -1 | n/a | -222 | -5.04K | 42.29K | -154.47K |
Shares Outstanding (Basic) | 12.82M | 12.82M | 55.04M | 51.83M | 27.03M | 23.52M | 23.45M | 18.89M | 12.64M | 8.67M | 10.05M | 10.05M | 10.05M |
Shares Outstanding (Diluted) | 12.82M | 12.82M | 55.04M | 51.83M | 27.03M | 23.52M | 23.45M | 18.89M | 12.64M | 8.67M | 10.05M | 10.05M | 10.05M |
EPS (Basic) | -2.83 | -4.3 | -0.92 | -0.64 | -2.57 | -1.34 | -2.14 | -1.96 | -1.73 | -2.75 | -0.87 | -0.77 | -1.05 |
EPS (Diluted) | -2.83 | -4.3 | -0.92 | -0.64 | -2.57 | -1.34 | -2.14 | -1.96 | -1.73 | -2.75 | -0.87 | -0.77 | -1.05 |
EBITDA | -52.29M | -51.99M | -49.59M | -31.46M | -69.10M | -31.58M | -50.18M | -37.00M | -21.76M | -21.65M | -8.63M | -7.54M | -10.54M |
Depreciation & Amortization | 3.30M | 3.20M | 2.28M | 1.82M | 340.00K | n/a | 1.00 | 1.00 | -421.00K | 135.95K | 59.57K | 130.78K | 125.60K |